Proliferative diabetic retinopathy with lymphocyte-rich epiretinal membrane associated with poor visual prognosis

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 12, 2009, Pages 5909-5912

  Kase, Satoru ^a   Saito, Wataru ^a   Ohno, Shigeaki ^a   Ishida, Susumu ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD20 ANTIGEN; CD45 ANTIGEN;

ADULT; AGED; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; EPIRETINAL MEMBRANE; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOCYTE COUNT; LYMPHOCYTE RICH EPIRETINAL MEMBRANE; LYMPHOCYTIC INFILTRATION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; VISUAL DISORDER; VITRECTOMY; CELL MOTION; ENZYME IMMUNOASSAY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; T LYMPHOCYTE; VISUAL ACUITY;

ADULT; AGED; ANTIGENS, CD20; ANTIGENS, CD3; ANTIGENS, CD45; CELL MOVEMENT; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PROGNOSIS; T-LYMPHOCYTES; VISUAL ACUITY; VITRECTOMY;

EID: 73349096024     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3767     Document Type: Article

References (15)

1. Cunha-Vaz J. Lowering the risk of visual impairment and blindness. Diabet Med. 1998;15(suppl 4):S47-S50.
2. Snead DR, James S, Snead MP. Pathological changes in the vitreo-retinal junction, 1: epiretinal membrane formation. Eye. 2008;22: 1310-1317.
3. Kase S, Saito W, Ohgami K, et al. Expression of erythropoietin receptor in human epiretinal membrane of proliferative diabetic retinopathy. Br J Ophthalmol. 2007;91:1376-1378.
4. Tang S, Scheiffarth OF, Thurau SR, Wildner G. Cells of the immune system and their cytokines in epiretinal membranes and in the vitreous of patients with proliferative diabetic retinopathy. Ophthalmic Res. 1993;25:177-185.
5. Miyamoto K, Ogura Y. Pathogenetic potential of leukocytes in diabetic retinopathy. Semin Ophthalmol. 1999;14:233-239.
6. Kase S, Yokoi M, Saito W, et al. Increased osteopontin levels in the vitreous of patients with diabetic retinopathy. Ophthalmic Res. 2007;39:143-147.
7. Tang S, Le-Ruppert KC. Activated T lymphocytes in epiretinal membranes from eyes of patients with proliferative diabetic reti-nopathy. Graefes Arch Clin Exp Ophthalmol. 1995;233:21-25.
8. Ascon M, Ascon DB, Liu M, et al. Renal ischemia-reperfusion leads to long term infiltration of activated and effector-memory T lymphocytes. Kidney Int. 2009;75:526-535.
9. Bresser P, Jansen HM, Weller FR, Lutter R, Out TA. T-cell activation in the lungs of patients with systemic sclerosis and its relation with pulmonary fibrosis. Chest. 2001;120:66S-68S
10. Krepler K, Polska E, Wedrich A, Schmetterer L. Ocular blood flow parameters after pars plana vitrectomy in patients with diabetic retinopathy. Retina. 2003;23:192-196.
11. Canton A, Martinez-Caceres EM, Hernandez C, et al. CD4-CD8 and CD28 expression in T cells infiltrating the vitreous fluid in patients with proliferative diabetic retinopathy: a flow cytometric analysis. Arch Ophthalmol. 2004;122:743-749.
12. Margolis R, Singh RP, Bhatnagar P, Kaiser PK. Intravitreal triam-cinolone as adjunctive treatment to laser panretinal photocoagu-lation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema. Acta Ophthalmol. 2008;86:105- 110.
13. Jonas JB, Hayler JK, Sofker A, Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol. 2001;131:468-471.
14. Almawi WY, Beyhum HN, Rahme AA, Rieder MJ. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J Leukoc Biol. 1996;60:563-572.
15. Slavin J, Uemori E, Hunt TK, Amento E. Transforming growth factor beta (TGF-beta) and dexamethasone have direct opposing effects on collagen metabolism in low passage human dermal fibroblasts in vitro. Growth Factors. 1994;11:205-213.